INFINITY PHARMACEUTICALS, INC. License Agreements
5 Contracts & Agreements
- Amended and Restated Development and License Agreement, dated as of December 24, 2012, by and between the Registrant and Intellikine, LLC (Filed With SEC on March 28, 2023)
- Amendment No. 4 to Amended and Restated Development and License Agreement, dated as of March 4, 2019, by and between the Registrant and Intellikine LLC (Filed With SEC on May 7, 2019)
- Third Amendment to Amended and Restated Development and License Agreement, dated July 26, 2017, by and between the Registrant and Intellikine LLC (Filed With SEC on November 7, 2017)
- AMENDMENT No. 2 TO AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on November 9, 2016)
- AMENDMENT TO AMENDEDAND RESTATED DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on November 10, 2014)
